Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies

Por Schweizer, Anja, Dejager, Sylvie, Foley, James E, Kothny, Wolfgang
Publicado em 2011

Clinical evidence and mechanistic basis for vildagliptin’s effect in combination with insulin

Por Schweizer, Anja, Foley, James E, Kothny, Wolfgang, Ahrén, Bo
Publicado em 2013

Vildagliptin-insulin combination improves glycemic control in Asians with type 2 diabetes

Por Kozlovski, Plamen, Foley, James, Shao, Qing, Lukashevich, Valentina, Kothny, Wolfgang
Publicado em 2013

Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial

Por Kothny, Wolfgang, Lukashevich, Valentina, Foley, James E., Rendell, Marc S., Schweizer, Anja
Publicado no Diabetologia (2015)

Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Tr...

Por Odawara, Masato, Yoshiki, Mika, Sano, Misako, Hamada, Izumi, Lukashevich, Valentina, Kothny, Wolfgang
Publicado no Diabetes Ther (2015)

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

Por Lukashevich, Valentina, Schweizer, Anja, Foley, James E, Dickinson, Sheila, Groop, Per-Henrik, Kothny, Wolfgang
Publicado em 2013

Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies

Por Kozlovski, Plamen, Fonseca, Marilia, Mohan, Viswanathan, Lukashevich, Valentina, Odawara, Masato, Paldánius, Päivi M., Kothny, Wolfgang
Publicado no Diabetes Obes Metab (2017)